Message from the Research Advisory Committee
The Research Advisory Committee (RAC) is responsible for overseeing the implementation of the NSLHD Research Strategy 2019-2024. We are delighted to report that almost a third of the initiatives identified by our stakeholders in the development of the strategy have been delivered, and we are on target to deliver the remaining initiatives within the five-year timeframe. The initiatives that have been delivered were predominately structural reviews and changes to the delivery of research support and infrastructure. Notable achievements to date include establishing a website presence for research, publishing an annual research highlights report, the development of a clinical trials reference group, maintaining ethics and governance review times within the Ministry of Health designated key performance metrics, and drafting a fundraising strategy, in conjunction with the NORTH Foundation. The initiatives that were not delivered are those that were halted or slowed due to the COVID-19 pandemic, such as hosting face to face research forums; these will be carried over to following years.
The inclusion of consumers in the strategy, from development to delivery, has been invaluable. In addition, with consumers sitting side-by side with our researchers and clinicians to provide feedback on their own experiences, as well as taking part in our trials and studies, has ensured we remain focused on delivering outcomes from research that will benefit our community in years to come. The district is now transitioning into delivery of the mid-term initiatives identified in the strategy; these are more strategic in nature and include, for example, the establishment of priority areas, the provision of support for early and mid-career researchers, and the further development of our district research culture. These initiatives are designed to embed research as a recognised and protected core business function, and to underpin our research as a strong and sustainable component of our core business. The Research Advisory Committee looks forward to partnering with our staff, our patients and our community to continue delivering our strategy, and to support our research throughout the remainder of 2021 and into 2022.
Rebeka Freckleton, Manager Research Strategy and Partnerships
6
RESEARCH ANNUAL REPORT 2020
Made with FlippingBook - professional solution for displaying marketing and sales documents online